Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 24Observational 4Expanded_access 1

Sponsor

Cancer Type

CNS 13Endocrine 5Head & Neck 2Gastrointestinal 2Thoracic 1Sarcoma 1Other solid neoplasm 1Genitourinary 1

Conditions

Solid Tumors 3Rhabdoid Tumor 2Wilms Tumor 1Solid Tumours 1Solid Tumor, Adult 1Solid Tumor Metastatic Cancer Advanced Cancer 1Solid Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Mesothelioma, Malignant 1Mesothelioma 1Meningeal Neoplasms 1Medulloblastoma 1Malignant Solid Tumour 1Hepatoblastoma 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Renal Cell 1Advanced Solid Tumor Cancer 1

Interventions

omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Neuroblastoma × Other solid neoplasm × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡